Crossmark

Design, screening and biological evaluation of novel fatty acid chain-modified oxyntomodulin-based derivatives with prolonged glucose-lowering ability and potent anti-obesity effects

Crossref DOI link: https://doi.org/10.1039/C9OB01132C

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Zhao, Lei

Wang, Baohua

Wang, Limin

Zhao, Xie

Chen, Zhe

Sun, Lixia https://orcid.org/0000-0001-5362-4675
License Information

Accepted Manuscript valid from 2020-07-30
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Lixia Sun (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 15 May 2019; Accepted 17 July 2019; Accepted Manuscript published 30 July 2019; Advance Article published 7 August 2019; Version of Record published 21 August 2019

Document is current

Any future updates will be listed below